NCT07053657View on ClinicalTrials.gov

Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China

NANot yet recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 31, 2025

Conditions
Cardiometabolic Risk Factors
Interventions
DRUG

Dietary Supplement: Vitamin D3

2000 IU per day for 6 weeks (two capsules of 800 IU plus one capsule of 400 IU), followed by 800 IU (one capsule of 800 IU) per day for 6 weeks.

DRUG

Dietary Supplement: Vitamin D3 placebo

Three capsules for 6 weeks, followed by one capsule for 6 weeks.

Trial Locations (1)

Unknown

Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER

NCT07053657 - Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China | Biotech Hunter | Biotech Hunter